Get the Stockscreener App
4.20
0.96%
0.04
Cibus Inc stock is traded at $4.20, with a volume of 68,087.
It is up +0.96% in the last 24 hours and up +37.70% over the past month.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
See More
Previous Close:
$4.16
Open:
$4.22
24h Volume:
68,087
Relative Volume:
0.34
Market Cap:
$109.73M
Revenue:
$1.82M
Net Income/Loss:
$-267.63M
P/E Ratio:
-0.2333
EPS:
-18
Net Cash Flow:
$-50.53M
1W Performance:
+0.96%
1M Performance:
+37.70%
6M Performance:
-75.38%
1Y Performance:
-63.00%
1-Day Range:
$4.0773
$4.29
1-Week Range:
$3.88
$4.57
52-Week Range:
$2.858
$23.18
Cibus Inc Stock (CBUS) Company Profile
Name
Cibus Inc
Sector
Industry
Phone
(858) 450-0008
Address
6455 NANCY RIDGE DRIVE, SAN DIEGO
Cibus Inc Stock (CBUS) Latest News
Cibus Confirms HT2 Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola - CropLife
Cibus Confirms its Herbicide Tolerance (HT2) Trait Shows Increased Tolerance to a Novel Herbicide for Weed Control in Canola - ForexTV.com
Cibus Breakthrough: New Herbicide-Resistant Canola Trait Shows Promise in Key Tests | CBUS Stock News - StockTitan
Cibus, Inc. (NASDAQ:CBUS) Short Interest Update - MarketBeat
Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call - StockTitan
Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close ... - Leader-Telegram
Cibus to Report Third Quarter 2024 Financial Results on November 7, 2024 After the Market Close and Host Conference Call - GlobeNewswire Inc.
Cibus (NASDAQ:CBUS) Receives “Buy” Rating from Canaccord Genuity Group - Defense World
Analyst Ratings For Cibus - Benzinga
Canaccord retains Buy rating on Cibus shares, cites royalty revenue - Investing.com India
Cibus announces $10 million cost savings from restructuring By Investing.com - Investing.com Australia
Cibus announces $10 million cost savings from restructuring - Investing.com
Cibus Inc. Announces Realigned Organization to Advance its Commercial Opportunities - The Manila Times
Truist Financial Corp Decreases Stake in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Cibus announces workforce reduction, cost-cutting measures - Investing.com
Cibus announces workforce reduction, cost-cutting measures By Investing.com - Investing.com Canada
Short Interest in Cibus, Inc. (NASDAQ:CBUS) Declines By 15.4% - MarketBeat
Cibus (CBUS) Shares Rise Significantly With Key Event Engagement - Stocks Telegraph
individual investors who own 43% along with institutions invested in Cibus, Inc. (NASDAQ:CBUS) saw increase in their holdings value last week - Yahoo Finance
Cibus, Inc. (NASDAQ:CBUS) surges 21%; retail investors who own 43% shares profited along with institutions - Simply Wall St
Cibus Technology to be Featured on InnovAction Stage at the Euroseeds2024 Congress - ForexTV.com
Cibus Inc (CBUS) Q2 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges - Yahoo Finance
Cibus stock plunges to 52-week low at $3.09 amid market challenges - Investing.com
Cibus names Carlo Broos as interim CFO By Investing.com - Investing.com Australia
Cibus names Carlo Broos as interim CFO - Investing.com India
Cibus Announces Carlo Broos as Interim CFO Following King’s Exit - TipRanks
Cibus, Inc. (NASDAQ:CBUS) Sees Large Increase in Short Interest - MarketBeat
Rhumbline Advisers Takes Position in Cibus, Inc. (NASDAQ:CBUS) - Defense World
Armistice Capital LLC Acquires New Position in Cibus, Inc. (NASDAQ:CBUS) - MarketBeat
Cibus stock plunges to 52-week low of $3.54 amid market challenges - Investing.com Australia
53,662 Shares in Cibus, Inc. (NASDAQ:CBUS) Purchased by Bank of New York Mellon Corp - Defense World
Unveiling 5 Analyst Insights On Cibus - Benzinga
Cibus (NASDAQ:CBUS) Price Target Cut to $23.50 by Analysts at Alliance Global Partners - Defense World
Cibus (NASDAQ:CBUS) PT Lowered to $23.50 at Alliance Global Partners - MarketBeat
Cibus to Participate in the Food+ Forum during the 79th Session of the United Nations General Assembly - StockTitan
Cibus announces partial exercise of underwriters' option - Investing.com
Cibus announces partial exercise of underwriters' option By Investing.com - Investing.com UK
Cibus (NASDAQ:CBUS) Price Target Lowered to $20.00 at Canaccord Genuity Group - Defense World
Expert Ratings For Cibus - Benzinga
Cibus (NASDAQ:CBUS) Given New $20.00 Price Target at Canaccord Genuity Group - MarketBeat
Cibus price target lowered to $20 from $21 at Canaccord - TipRanks
In the Green: Cibus Inc (CBUS) Closes at 3.60, Up/Down -28.95 from Previous Day - The Dwinnex
Cibus sets price for 3 million share public offering By Investing.com - Investing.com Canada
Cibus shares price target cut to $20 by Canaccord Genuity - Investing.com
Cibus announces public offering of Class A stock By Investing.com - Investing.com Australia
Cibus announces strategic realignment and trait development updates By Investing.com - Investing.com Australia
Company’s Banking Stock: Dissecting a -60.21% Quarterly Revenue Decline Amid Growth - The InvestChronicle
Dow Jumps Over 100 Points; Fed Cuts Interest Rates By 0.5% - Benzinga
Cibus Inc Stock (CBUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.20%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):